Levocuqin CR Tablets (Levodropropizine)

Adult dose

Adults: Take 1 tablet per dose (equivalent to 90mg of levodropropizine) orally twice daily. This is an extended-release formulation; swallow it whole without splitting or crushing.

This medication should not be used by anyone who is allergic to this medication or its ingredients. It is best not to administer this medication to patients with excessive bronchial mucus secretion. Do not use in patients with disrupted mucociliary function, such as those with Kartagener's syndrome or ciliary dyskinesia. Pregnant women, women who may become pregnant, and nursing mothers should not use this medication. Patients with severely impaired liver function should avoid taking this medication. Since this medication contains lactose, it is advisable for patients with lactose intolerance or related genetic metabolic disorders to refrain from using it. Caution must be exercised in patients with significantly weakened heart function or severely impaired kidney function, as well as in the elderly. This prolonged-release formulation may not be suitable for children, so using another formulation is recommended. Taking this medication may occasionally cause gastrointestinal symptoms such as nausea, dyspepsia, and constipation. Central nervous system symptoms such as drowsiness, headache, and dizziness can commonly occur, so caution is advised. Symptoms such as eyelid swelling or dizziness in the ear have been reported rarely. In urinalysis, increased white blood cells may commonly appear, and liver function test results may be elevated. Care should be taken while driving or operating machinery, as this medication may cause drowsiness, especially when taken with alcohol, which can exacerbate symptoms. This medication may enhance the effects when taken with sedatives, so patients on such medications should consult healthcare professionals. Pregnant women and nursing mothers should avoid taking this medication. This medication should be stored in a safe place out of reach of children, and care should be taken not to transfer it to another container, as this may alter its quality.

• nausea
• indigestion
• constipation
• drowsiness
• headache
• dizziness
• orthostatic hypotension
• eyelid edema
• increased leukocytes in urine
• elevated ALT

This medication should be stored in a sealed container to protect it from air and moisture. Additionally, it is important to store it at room temperature, between 1 and 30 degrees Celsius, to maintain its effectiveness.

Appearance

Biconvex prolonged-release tablet consisting of a white to pale yellow upper layer and a white lower layer.

Package unit

30 tablets/bottle, 300 tablets/bottle